IL49288A - (cyclopropylalkyl)amine derivatives - Google Patents

(cyclopropylalkyl)amine derivatives

Info

Publication number
IL49288A
IL49288A IL49288A IL4928873A IL49288A IL 49288 A IL49288 A IL 49288A IL 49288 A IL49288 A IL 49288A IL 4928873 A IL4928873 A IL 4928873A IL 49288 A IL49288 A IL 49288A
Authority
IL
Israel
Prior art keywords
formula
compound
compounds
radical
cyclopropyl
Prior art date
Application number
IL49288A
Other languages
English (en)
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of IL49288A publication Critical patent/IL49288A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/06—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms
    • C07C335/08—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/18—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
IL49288A 1972-12-28 1973-12-04 (cyclopropylalkyl)amine derivatives IL49288A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5988672A GB1453703A (en) 1972-12-28 1972-12-28 Substituted cyclopropylmethylamines processes for their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
IL49288A true IL49288A (en) 1977-06-30

Family

ID=10484588

Family Applications (3)

Application Number Title Priority Date Filing Date
IL43749A IL43749A (en) 1972-12-28 1973-12-04 Cyclopropylmethylamine derivatives of n-containing heterocyclic compounds their production and pharmaceutical compositions containing them
IL49288A IL49288A (en) 1972-12-28 1973-12-04 (cyclopropylalkyl)amine derivatives
IL49288A IL49288A0 (en) 1972-12-28 1976-03-25 Novel cyclopropylamine derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL43749A IL43749A (en) 1972-12-28 1973-12-04 Cyclopropylmethylamine derivatives of n-containing heterocyclic compounds their production and pharmaceutical compositions containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL49288A IL49288A0 (en) 1972-12-28 1976-03-25 Novel cyclopropylamine derivatives

Country Status (20)

Country Link
US (1) US3988464A (ja)
JP (3) JPS5335949B2 (ja)
AR (2) AR207336A1 (ja)
AT (1) AT333272B (ja)
BE (1) BE809179A (ja)
CH (2) CH592641A5 (ja)
CS (1) CS186258B2 (ja)
DD (1) DD110869A5 (ja)
DE (1) DE2362754C2 (ja)
DK (1) DK145574C (ja)
ES (1) ES421879A1 (ja)
FI (1) FI59999C (ja)
FR (1) FR2212143B1 (ja)
GB (1) GB1453703A (ja)
HU (1) HU169273B (ja)
IL (3) IL43749A (ja)
NL (1) NL169472C (ja)
SE (1) SE388420B (ja)
SU (2) SU505348A3 (ja)
ZA (1) ZA739694B (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2358890A1 (fr) * 1976-05-24 1978-02-17 Science Union & Cie Nouvelles aryl trifluoroethylamines, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
FR2432513A1 (fr) * 1977-10-24 1980-02-29 Merieux Inst Nouveaux derives de la thiazoline et leur application comme medicaments
DE2831600A1 (de) * 1978-07-19 1980-01-31 Boehringer Sohn Ingelheim Neue substituierte 2-phenylamino-1, 3-tetrahydropyrimidine-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
FR2444673A1 (fr) * 1978-12-20 1980-07-18 Science Union & Cie Nouvelles trifluoroethylamines, leurs procedes d'obtention et leur emploi comme medicament
FR2669927B1 (fr) * 1990-11-29 1994-04-08 Adir Cie Nouveaux derives de guanidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE19716237A1 (de) * 1997-04-18 1998-10-22 Basf Ag Substituierte Benzyloxyimino-Verbindungen
AUPP020297A0 (en) * 1997-11-05 1997-11-27 University Of Melbourne, The A novel receptor, and compounds which bind thereto
PL372695A1 (en) 2002-06-19 2005-07-25 Solvay Pharmaceuticals Gmbh Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
US20060283363A1 (en) * 2005-06-07 2006-12-21 Wollman Albert E Potato Planter Improvement to Reduce Skips and Rolling
RU2534617C2 (ru) * 2012-09-21 2014-11-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Оренбургский государственный университет" Регулятор коллективного поведения ("чувство кворума") у бактерий
MX2016001714A (es) 2013-08-09 2016-10-03 Ardelyx Inc Compuestos y metodos para inhibir el transporte de fosfato.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626067A (en) * 1965-07-01 1971-12-07 Du Pont Substituted oxazolines, useful as pharmaceuticals
NL128801C (ja) * 1965-11-19
DE1670752A1 (de) * 1966-09-27 1970-12-23 Bayer Ag Verfahren zur Herstellung von 2-Phenylamino-oxazolinen
DE1670751A1 (de) * 1966-09-27 1970-12-23 Bayer Ag Verfahren zur Herstellung von 2-Phenylamino-2-oxazolinen
DE1670753A1 (de) * 1966-09-27 1970-07-16 Bayer Ag Verfahren zur Herstellung von 2-Cycloalkylaminooxazolinen

Also Published As

Publication number Publication date
ES421879A1 (es) 1976-08-01
AR207336A1 (es) 1976-09-30
HU169273B (ja) 1976-10-28
NL7317536A (ja) 1974-07-02
ZA739694B (en) 1975-02-26
DK145574B (da) 1982-12-13
JPS5335949B2 (ja) 1978-09-29
JPS544955B2 (ja) 1979-03-12
GB1453703A (en) 1976-10-27
BE809179A (fr) 1974-06-27
NL169472B (nl) 1982-02-16
FI59999B (fi) 1981-07-31
DK145574C (da) 1983-05-30
ATA1089973A (de) 1976-03-15
SE388420B (sv) 1976-10-04
JPS504084A (ja) 1975-01-16
US3988464A (en) 1976-10-26
FR2212143B1 (ja) 1977-03-11
DE2362754A1 (de) 1974-07-11
CS186258B2 (en) 1978-11-30
CH592641A5 (ja) 1977-10-31
FI59999C (fi) 1981-11-10
IL43749A0 (en) 1974-03-14
AU6340073A (en) 1975-06-12
SU505348A3 (ru) 1976-02-28
CH590253A5 (ja) 1977-07-29
FR2212143A1 (ja) 1974-07-26
AR211914A1 (es) 1978-04-14
JPS5356664A (en) 1978-05-23
IL43749A (en) 1977-06-30
JPS5422978B2 (ja) 1979-08-10
DE2362754C2 (de) 1985-11-21
IL49288A0 (en) 1976-05-31
JPS5359665A (en) 1978-05-29
SU591136A3 (ru) 1978-01-30
DD110869A5 (ja) 1975-01-12
NL169472C (nl) 1982-07-16
AT333272B (de) 1976-11-10

Similar Documents

Publication Publication Date Title
US3928412A (en) 1-Aryloxy-3-ureidoalkylamino-2-propanols
US3226426A (en) 4-hydroxy-2-butynyl carbamates
EP0773937A1 (fr) Nouvelles piperazides derivees d'aryl piperazine, leurs procedes de preparation, leur utilisation a titre de medicament et les compositions pharmaceutiques les comprenant
IL49288A (en) (cyclopropylalkyl)amine derivatives
CA1116611A (en) Imidazole derivatives exhibiting anticonvulsant activity
US2722529A (en) Amides of certain l-amevoalkyl-x-phenyl
FR2664269A1 (fr) Nouveaux derives n-substitues d'alpha-mercapto alkylamines, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant.
US3905996A (en) Imidazolidones
Ferris et al. The Preparation of Carbodiimides, Isocyanates, and Isothiocyanates by Metal Ion-assisted Elimination of Mercaptan1, 2
NO761050L (ja)
IWAKURA et al. O-Alkyl-and Aryl-N, N-ethyleneurethanes. I. Preparation and Reaction with Amines1
US2415786A (en) Unsymmetrically substituted piperazines
JPS6326748B2 (ja)
FI56834C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva bensensulfonylkarbamid
EP0439059A2 (en) 1-Phenylalkyl-3-phenylurea derivative
US4102890A (en) 2-Amino oxazolines and process for making the same
Jacobson N-substituted α-aminoisobutyronitriles from acetone cyanohydrin
US3888927A (en) Anti-inflammatory n,n'-disubstituted amidines
US2671798A (en) 2, 2-diphenyl-3-methyl-4-chlorobutyronitrile and processes for preparing the same
US6066754A (en) Process for manufacturing N-alkoxy(or aryloxy)carbonyl isothiocyanate derivatives using N,N-dialkylarylamine as catalyst
HU187706B (en) Process for preparing n-/aryl-oxy.alkyl/-n'-/amino-alkyl/-carbamide derivatives
US3439033A (en) Benzene-sulfonyl ureas
Speziale et al. Pyranylation of Amides
US6184412B1 (en) Process for manufacture of N-alkoxy(or aryloxy)carbonyl isothiocyanate derivatives in the presence of N,N-dialkylarylamine catalyst and aqueous solvent
US3917679A (en) Quaternary ammonium salts of N-dialkylaminoalkyl-N-(2-indanyl)anilines